Morgan Stanley upgrades Johnson & Johnson, sees upside on robust drug pipeline

Strong Bullish 100.0
Morgan Stanley's price target implies that shares of Johnson & Johnson could rise another 17%.
Read Source Login to use Pulse AI

Pulse AI Analysis

Pulse analysis not available yet. Click "Get Pulse" above.

This analysis was generated using Pulse AI, Glideslope's proprietary AI engine designed to interpret market sentiment and economic signals. Results are for informational purposes only and do not constitute financial advice.